290 related articles for article (PubMed ID: 8455760)
1. The treatment of anaplastic oligodendrogliomas and mixed gliomas.
Kyritsis AP; Yung WK; Bruner J; Gleason MJ; Levin VA
Neurosurgery; 1993 Mar; 32(3):365-70; discussion 371. PubMed ID: 8455760
[TBL] [Abstract][Full Text] [Related]
2. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
[TBL] [Abstract][Full Text] [Related]
3. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
Soffietti R; Rudà R; Bradac GB; Schiffer D
Neurosurgery; 1998 Nov; 43(5):1066-73. PubMed ID: 9802850
[TBL] [Abstract][Full Text] [Related]
4. Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon.
Sunyach MP; Pommier P; Martel Lafay I; Guyotat J; Ginestet G; Jouanneau E; Jouvet A; Sindou M; Bret P; Carrie C; Frappaz D
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):296-303. PubMed ID: 12694851
[TBL] [Abstract][Full Text] [Related]
5. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
6. Chemotherapy for aggressive or anaplastic high grade oligodendrogliomas and oligoastrocytomas: better than a salvage treatment.
Bouffet E; Jouvet A; Thiesse P; Sindou M
Br J Neurosurg; 1998 Jun; 12(3):217-22. PubMed ID: 11013683
[TBL] [Abstract][Full Text] [Related]
7. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
Glass J; Hochberg FH; Gruber ML; Louis DN; Smith D; Rattner B
J Neurosurg; 1992 May; 76(5):741-5. PubMed ID: 1564535
[TBL] [Abstract][Full Text] [Related]
8. Aggressive oligodendroglioma: a chemosensitive tumor.
Cairncross JG; Macdonald DR; Ramsay DA
Neurosurgery; 1992 Jul; 31(1):78-82. PubMed ID: 1641113
[TBL] [Abstract][Full Text] [Related]
9. Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy.
Boiardi A; Silvani A; Pozzi A; Farinotti M; Fariselli L; Broggi G; Salmaggi A
J Neurooncol; 1997 Sep; 34(2):179-85. PubMed ID: 9210066
[TBL] [Abstract][Full Text] [Related]
10. Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III.
Kristof RA; Neuloh G; Hans V; Deckert M; Urbach H; Schlegel U; Simon M; Schramm J
J Neurooncol; 2002 Sep; 59(3):231-7. PubMed ID: 12241120
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
Cairncross G; Macdonald D; Ludwin S; Lee D; Cascino T; Buckner J; Fulton D; Dropcho E; Stewart D; Schold C
J Clin Oncol; 1994 Oct; 12(10):2013-21. PubMed ID: 7931469
[TBL] [Abstract][Full Text] [Related]
12. A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.
Streffer J; Schabet M; Bamberg M; Grote EH; Meyermann R; Voigt K; Dichgans J; Weller M
J Neurol; 2000 Apr; 247(4):297-302. PubMed ID: 10836623
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.
Chinot OL; Honore S; Dufour H; Barrie M; Figarella-Branger D; Muracciole X; Braguer D; Martin PM; Grisoli F
J Clin Oncol; 2001 May; 19(9):2449-55. PubMed ID: 11331324
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of low-grade oligodendroglioma and mixed glioma.
Olson JD; Riedel E; DeAngelis LM
Neurology; 2000 Apr; 54(7):1442-8. PubMed ID: 10751254
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Burch PA; Schaefer PL; Dinapoli RP; Novotny PJ; Scheithauer BW; Rowland KM; Vukov AM; Mailliard JA; Morton RF
J Clin Oncol; 1998 Sep; 16(9):2953-8. PubMed ID: 9738563
[TBL] [Abstract][Full Text] [Related]
16. [Place of chemotherapy and radiotherapy in the management of oligodendrogliomas].
Cartalat-Carel S; Chinot O; Honnorat J
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):379-92. PubMed ID: 16292180
[TBL] [Abstract][Full Text] [Related]
17. Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Cairncross G; Swinnen L; Bayer R; Rosenfeld S; Salzman D; Paleologos N; Kaminer L; Forsyth P; Stewart D; Peterson K; Hu W; Macdonald D; Ramsay D; Smith A;
Neuro Oncol; 2000 Apr; 2(2):114-9. PubMed ID: 11303620
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
[TBL] [Abstract][Full Text] [Related]
20. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]